Mere: Clinical Intelligence, Productized
The first adaptive wellness platform built on twenty years of clinical infrastructure. Raising $1.0M Pre-Seed SAFE at a $9M post-money cap to prove retention and scale the clinic network.
$1.0M
Raise Amount
Pre-Seed SAFE
$9M
Post-Money Cap
Valuation
12–15mo
Runway
To Seed Position
$410K
Exit MRR Target
12-Month Base Case
Investment Thesis
The $60B supplement industry has a structural failure: products are static, outcomes are unmeasured, and 68-75% of subscribers leave within 90 days. Clinics deliver outcomes but cannot scale.
Mere closes this gap with the only platform that measures biometric data (Mere Pulse), interprets it (NORA AI), delivers personalized protocols (NanoActives), and adapts every 30 days based on response data.
The founding team already controls distribution (1,000+ practitioner alumni), manufacturing (Okchundang, 3.1M+ prescriptions), clinical validation (Dr. Lao, 370+ publications), and hardware execution.
What This Capital Unlocks
Manufacturing & Inventory
Product & Engineering
Marketing & Content
Working Capital & Operations
The Closed-Loop Platform
Measure
Mere Pulse
Arterial pulse waveform every 20 min
Interpret
NORA AI
92% concordance, organ-function indices
Deliver
NanoActives
8 protocols, patented micro-beads
Adapt
Mere App
Formula adapts every 30 days
12-Month Milestone Roadmap
Launch
- 20 owned practitioners activated
- NanoActives subscription live
- Mere App MVP
- First cohort data
Scale Clinic Network
- 120 practitioners activated
- VUIM alumni outreach
- Content production library
- Cohort retention validation
Prove Retention
- 300 practitioners activated
- MRR sustained above $150K
- Ring introduction gate evaluation
- IRB replication study launch
Seed Position
- 400 practitioners activated
- 5,316 active subscribers
- $410K normalized MRR
- Seed round positioning
The Founding Team
Byung Kim
Co-Founder & CEO
Will Yeung
Co-Founder & CTO
Sung Koo
Co-Founder & VP of Supplement Technologies
Dr. Lixing Lao
VP of Clinical Research
Spring Xu
VP of Wearable Technologies
Interested in Mere?
Review the full financial model and diligence materials, or reach out directly to discuss the opportunity.
This is not an offer to sell securities. Materials provided for informational purposes only. General wellness; non-diagnostic.